Eyenovia Inc (NAS:EYEN)
$ 0.78 0.01 (1.3%) Market Cap: 42.02 Mil Enterprise Value: 50.14 Mil PE Ratio: 0 PB Ratio: 19.50 GF Score: 21/100

Q4 2019 Eyenovia Inc Earnings Call Transcript

Mar 25, 2020 / 08:30PM GMT
Release Date Price: $2.34 (-0.85%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to today's program, Eyenovia, Inc. Fourth Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, today's program is being recorded.

And now I'd like to introduce your host for today's program, Alex Lobo from The Ruth Group. Please go ahead.

Alexander Lobo;The Ruth Group;AVP
IR,

Good afternoon, and welcome to Eyenovia's Fourth Quarter and Full Year 2019 Earnings Conference Call and Audio Webcast. With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; John Gandolfo, Eyenovia's Chief Financial Officer; and Michael Rowe, Eyenovia's Vice President of Commercial.

Earlier this afternoon, Eyenovia issued a press release announcing financial results for the 3 months and full year ended December 31, 2019. We encourage everyone to read today's press release as well as Eyenovia's annual report on Form 10-K which can be found with the SEC. The company's press release and annual report will also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot